Completed
A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet
NCT01769677
- Conditions
- Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, +1 more
- Locations
-
- Teva Investigational Site 10470 Austin, Texas, United States